July 9, 2018
Physicians at UC San Diego Health are now offering prostate artery embolization as a new treatment option for men with benign prostatic hyperplasia, or an enlarged prostate. The minimally invasive procedure is an alternative to surgery, with no hospital stay, little operative pain and lower cost.
September 25, 2013
A team of cancer researchers at the University of California, San Diego has identified the existence of precursor cells in early prostate cancers. These cells are resistant to androgen-deprivation therapy, and may drive the subsequent emergence of recurrent or metastatic prostate cancer.
April 25, 2023
New UC San Diego Health transperineal prostate biopsy procedure now offered in clinic setting.
February 7, 2013
…its first-ever fundraiser for prostate cancer research, “Breakfast with Champions,” on Friday, Feb. 22 at the La Jolla Country Club. The event will feature Pro Football Hall of Famers and prostate cancer survivors Mike Haynes and Deacon Jones who will discuss their experiences as champions, both on and off the…
October 18, 2011
Study Shows Increased Prostate Cancer Risk from Vitamin E Supplements Dr. J. Kellogg Parsons Men who took 400 international units (I.U.) of vitamin E daily had more prostate cancers compared to men who took a placebo, according to an updated review of data from the Selenium and Vitamin E Cancer…
August 12, 2014
Oncologists at UC San Diego Moores Cancer Center are the first in San Diego to meld MRI technology with a traditional ultrasound prostate exam to create a three-dimensional map of the prostate that allows physicians to view growths that were previously undetectable.
April 29, 2015
…and the immune cells it activates — to destroy prostate tumors. This novel combination therapy, termed chemoimmunotherapy, achieved near complete remission in mouse models of advanced prostate cancer. The study is published April 29 in Nature.
May 6, 2019
University of California San Diego School of Medicine researchers report that men treated with medications for benign prostatic hyperplasia (enlarged prostate) experienced a two-year delay in diagnosis of their prostate cancer and were twice as likely to have advanced disease upon diagnosis.
October 11, 2011
…international units (I.U.) of vitamin E daily had more prostate cancers compared to men who took a placebo, according to an updated review of data from the Selenium and Vitamin E Cancer Prevention (SELECT) Trial. The results of this update will appear October 12, 2011, in the Journal of the…
November 3, 2020
Researchers with UC San Diego School of Medicine and Moores Cancer Center say active surveillance is safe for African American men with low-risk prostate cancer.